Related Experiment Video

Updated: Jun 6, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.4K

Viral mimicry evasion: a new role for oncogenic KRAS mutations

Raymond Chen1,2, Aobo He1,2, Daniel D De Carvalho1,2

  • 1Department of Medical Biophysics, University of Toronto, Canada.

Molecular Oncology
|November 26, 2024
PubMed

Insights

Oncogenic KRAS mutations hinder the innate immune response by suppressing viral mimicry. Targeting KRAS reactivates this response, enhancing cancer immunotherapy effectiveness in resistant tumors.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Viral mimicry, an innate immune response to endogenous double-stranded RNA (dsRNA), has therapeutic potential in cancer, particularly with immune checkpoint inhibition (ICI).
  • Oncogenic mutations can evade tumor suppression mechanisms, including viral mimicry, contributing to malignant transformation and therapy resistance.

Purpose of the Study:

  • To investigate the role of KRAS, a common oncogene, in regulating viral mimicry and response to ICI therapy.
  • To identify mechanisms by which KRAS mutations affect the dsRNA-sensing pathway and immune response in colorectal cancer.

Main Methods:

  • Utilized a colorectal cancer model resistant to ICI therapy.
  • Investigated the interaction between KRAS mutations, AKT and STAT3 signaling pathways, and the RNA-binding protein DDX60.
  • Assessed the impact of DDX60 overexpression and KRAS targeting on dsRNA levels, viral mimicry, and ICI efficacy.

Main Results:

  • Identified KRAS as a negative regulator of dsRNA and viral mimicry in ICI-resistant colorectal cancer.
  • Demonstrated that oncogenic KRASG12D downregulates DDX60 via the AKT/STAT3 pathway, inhibiting viral mimicry.
  • Showed that restoring DDX60 or targeting KRASG12D increases dsRNA, activates viral mimicry, and potentiates ICI treatment.

Conclusions:

  • KRAS acts as a key suppressor of viral mimicry, and its oncogenic mutations contribute to immune evasion in cancer.
  • Targeting KRAS presents a promising strategy to sensitize "cold" tumors to ICI therapy by reactivating the innate immune response.
  • Oncogenic mutations can actively subvert anti-tumor immunity, highlighting the importance of understanding these evasion mechanisms for effective cancer treatment.
Keywords:
DDX60KRAScolorectal cancerdsRNAimmune checkpoint inhibitionviral mimicry

More Related Videos

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

5.6K
Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus11:28

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

Published on: October 7, 2011

11.0K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
3